ArriVent BioPharma (AVBP) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.9
-1.49
-1.08
-0.66

Details

Expected EPS
-0.895156
Actual EPS
-0.96
Surprise EPS
-0.06
Surprise Percent
-7.24%

Description

⁨ArriVent BioPharma⁩ (⁦AVBP⁩) has reported earnings of ⁦-0.96⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts